A new Yale study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug.
The study is based on Phase 3 clinical trials using baricitinib, a Janus kinase (JAK) inhibitor, to treat alopecia areata, an often disfiguring skin disease characterized by rapid loss of scalp hair, and sometimes eyebrows and eyelashes.
“This is so exciting, because …
Positive News Foundation is a certified non-profit sharing only the best positive world news.
All copyrights belong to the source.
Source image: Yalenews/ GoodNewsNetwork.org
Source text: GoodNewsNetwork.org
Original title: New Treatment Helps Alopecia Patients Regrow Their Hair